Bajaj Healthcare Live BSE/NSE | Bajaj Healthcare Fundamenta data | Bajaj Healthcare Balance sheet | Bajaj Healthcare Quarterly Results | Bajaj Healthcare Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

632.21
18.30
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

718.98
N/A
4.97

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.63
12.54
7.69

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.41
9.83
4.02

PAT CAGR (%)

10 Years
5 Years
3 Years

18.11
22.37
13.99

P:E (Median)

8 Years
5 Years
3 Years

-
-
19.81

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.94

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
9.21

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 140 92 53% 118 0 0 99 0 0 101 0 0
Expenses 114 83 38% 103 0 0 86 0 0 92 0 0
EBITDA 25 9 183% 16 0 0 14 0 0 9 0 0
EBIDTM 18% 10% 13% 0% 14% 0% 9% 0%
Other Income 1 0 120% 3 0 0 0 0 0 0 0 0
Interest 2 2 12% 1 0 0 2 0 0 2 0 0
Depreciation 4 3 28% 3 0 0 3 0 0 3 0 0
PBT 20 5 342% 14 0 0 9 0 0 5 0 0
Tax 5 1 272% 4 0 0 3 0 0 1 0 0
PAT 15 3 372% 10 0 0 6 0 0 3 0 0
PATM 11% 4% 8% 0% 6% 0% 3% 0%
EPS 11.08 2.35 371% 6.96 0.00 0 4.62 0.00 0 2.38 0.00 0

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales - 362 325 290 207 200 197 186 157 130 110 Net Sales Growth - 11% 12% 40% 4% 2% 6% 19% 20% 18% Cost Of Goods Sold - 215 197 178 111 106 111 113 99 81 66 Gross Profit - 147 128 112 96 95 86 72 58 49 44 GP Margin - 41% 39% 39% 46% 47% 44% 39% 37% 38% 40% Total Expenditure - 313 282 250 176 170 168 166 144 119 96 Power & Fuel Cost - 24 22 20 17 14 13 11 10 9 7 % Of Sales - 7% 7% 7% 8% 7% 7% 6% 6% 7% 6% Employee Cost - 28 25 22 20 17 14 13 11 10 9 % Of Sales - 8% 8% 7% 9% 8% 7% 7% 7% 8% 8% Manufacturing Exp. - 29 25 22 20 23 23 21 17 11 9 % Of Sales - 8% 8% 7% 10% 12% 12% 11% 11% 9% 8% General & Admin Exp. - 8 7 5 6 6 5 5 4 4 4 % Of Sales - 2% 2% 2% 3% 3% 3% 3% 2% 3% 4% Selling & Distn. Exp. - 1 2 2 1 1 1 1 1 1 1 % Of Sales - 0% 1% 1% 1% 1% 1% 1% 1% 1% 1% Miscellaneous Exp. - 8 5 3 2 3 1 2 2 2 1 % Of Sales - 2% 2% 1% 1% 2% 0% 1% 2% 2% 0% EBITDA - 48 43 39 31 30 29 20 13 11 14 EBITDA Margin - 13% 13% 14% 15% 15% 15% 11% 8% 9% 12% Other Income - 3 1 2 2 0 0 0 0 0 1 Interest - 7 8 8 8 8 8 7 6 5 4 Depreciation - 12 11 11 11 9 9 9 8 6 5 PBT - 32 24 23 14 14 12 3 -2 1 6 Tax - 10 8 8 6 5 4 1 0 1 2 Tax Rate - 31% 33% 33% 43% 39% 37% 36% 31% 67% 28% PAT - 22 16 15 8 8 8 2 -1 0 4 PAT before Minority Interest - 22 16 15 8 8 8 2 -1 0 4 Minority Interest - 0 0 0 0 0 0 0 0 0 0 PAT Margin - 6% 5% 5% 4% 4% 4% 1% -1% 0% 4% PAT Growth - 38% 7% 94% -5% 9% 258% 298% -394% -92% EPS - 16.30 11.82 11.01 5.67 5.94 5.44 1.52 -0.77 0.26 3.09

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

362

325

290

207

200

197

186

157

130

110

Net Sales Growth

11%

12%

40%

19%

20%

18%

Cost Of Goods Sold

215

197

178

111

106

111

113

Gross Profit

147

128

112

GP Margin

41%

39%

46%

47%

44%

39%

37%

38%

40%

Total Expenditure

313

282

250

176

170

168

166

144

119

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

10%

12%

11%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

13%

14%

15%

11%

12%

Other Income

Interest

Depreciation

PBT

-2

Tax

Tax Rate

31%

33%

43%

39%

37%

36%

31%

67%

28%

PAT

-1

PAT before Minority Interest

-1

Minority Interest

PAT Margin

-1%

PAT Growth

38%

94%

-5%

258%

298%

-394%

-92%

EPS

16.30

11.82

11.01

5.67

5.94

5.44

1.52

-0.77

0.26

3.09

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 152 129 114 99 89 82 31 29 30 30 Share Capital 14 7 7 7 7 4 4 4 4 4 Total Reserves 138 122 107 92 82 78 28 25 27 26 Non-Current Liabilities 28 20 23 28 32 22 14 16 17 12 Secured Loans 23 16 20 24 27 18 9 16 16 11 Unsecured Loans 1 1 2 2 4 5 6 1 1 1 Long Term Provisions 2 1 1 0 0 0 0 0 0 0 Current Liabilities 146 117 131 93 88 85 99 85 74 65 Trade Payables 48 30 43 19 16 23 31 20 19 17 Other Current Liabilities 31 26 26 20 20 19 19 15 16 12 Short Term Borrowings 58 55 55 39 42 37 49 47 35 30 Short Term Provisions 9 7 7 15 10 5 1 4 4 7 Total Liabilities 326 267 268 219 209 189 145 130 121 107 Net Block 135 128 127 128 130 108 56 54 46 34 Gross Block 240 222 210 200 191 162 100 90 74 57 Accumulated Depreciation 106 94 83 72 62 53 45 36 28 22 Non Current Assets 145 130 129 128 131 110 59 59 59 50 Capital Work in Progress 5 1 2 0 1 1 3 5 13 15 Non Current Investment 5 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 0 0 0 0 0 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 181 137 140 91 78 79 86 71 62 57 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 39 30 34 17 20 18 23 16 18 20 Sundry Debtors 100 78 80 53 43 52 55 45 35 26 Cash & Bank 4 8 8 1 0 1 1 0 1 0 Other Current Assets 37 2 2 3 15 9 7 10 9 11 Short Term Loans & Adv. 34 19 15 18 13 7 5 8 7 9 Net Current Assets 34 20 8 -1 -10 -6 -13 -13 -11 -8 Total Assets 326 267 268 219 209 189 145 130 121 107

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

152

129

114

Share Capital

Total Reserves

138

122

107

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

146

117

131

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

326

267

268

219

209

189

145

130

121

107

Net Block

135

128

127

128

130

108

Gross Block

240

222

210

200

191

162

100

Accumulated Depreciation

106

Non Current Assets

145

130

129

128

131

110

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

181

137

140

Current Investments

Inventories

Sundry Debtors

100

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-1

-10

-6

-13

-11

-8

Total Assets

326

267

268

219

209

189

145

130

121

107

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 10 Mar 09
Cash From Operating Activity 21 25 17 22 25 28 17 0 0 PBT 32 24 23 14 14 12 3 0 0 Adjustment 19 20 19 19 17 17 16 0 0 Changes in Working Capital -22 -6 -19 -6 0 0 -2 0 0 Cash after chg. in Working capital 30 38 23 27 30 29 18 0 0 Interest Paid 0 0 0 0 0 0 0 0 0 Tax Paid -9 -13 -6 -5 -5 -1 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -28 -13 -12 -8 -31 -17 -9 0 0 Net Fixed Assets -22 -12 -12 -7 -30 -60 -47 -11 Net Investments -5 0 0 0 0 0 0 0 Others 0 -1 0 -1 -1 43 39 11 Cash from Financing Activity 3 -13 2 -13 5 -11 -8 0 0 Net Cash Inflow / Outflow -4 0 7 0 0 0 1 0 0 Opening Cash & Equivalents 8 8 1 0 1 1 0 0 0 Closing Cash & Equivalent 4 8 8 1 0 1 1 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 10

Mar 09

Cash From Operating Activity

PBT

Adjustment

Changes in Working Capital

-22

-6

-19

-6

-2

Cash after chg. in Working capital

Interest Paid

Tax Paid

-9

-13

-6

-5

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-28

-13

-12

-8

-31

-17

-9

Net Fixed Assets

-22

-12

-7

-30

-60

-47

-11

Net Investments

-5

Others

-1

Cash from Financing Activity

-13

-11

-8

Net Cash Inflow / Outflow

-4

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 81 64 53 72 34 28 22 21 21 21 ROA 8% 6% 6% 4% 4% 4% 2% -1% 0% 4% ROE 22% 20% 18% 11% 20% 22% 7% -4% 1% 16% ROCE 21% 20% 18% 15% 18% 19% 11% 5% 7% 15% Fixed Asset Turnover 1.77 1.71 1.60 1.18 1.26 1.66 2.15 2.09 2.17 2.26 Receivable days 79 78 74 76 77 89 88 85 78 75 Inventory Days 31 31 28 29 31 35 35 36 48 50 Payable days 45 47 45 36 41 57 54 47 53 66 Cash Conversion Cycle 65 63 58 68 67 66 70 74 73 59 Total Debt/Equity 0.81 0.91 1.19 0.76 1.75 1.77 2.25 2.40 2.01 1.55 Interest Cover 6 4 4 3 3 2 1 1 1 2

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

-1%

ROE

22%

20%

18%

11%

20%

22%

-4%

16%

ROCE

21%

20%

18%

15%

18%

19%

11%

15%

Fixed Asset Turnover

1.77

1.71

1.60

1.18

1.26

1.66

2.15

2.09

2.17

2.26

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.81

0.91

1.19

0.76

1.75

1.77

2.25

2.40

2.01

1.55

Interest Cover

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

BSE: 539872 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

BSE: 539872 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update